Catheter-based renal denervation is discussed as a promising minimally invasive treatment for hypertension.
Answers are grounded in this paper and cite their sources.
Should not yet alter hypertension practice; leaves open renal denervation's role pending randomized outcome data.
Catheter-based renal denervation (RDN) has evolved recently as a promising minimally invasive treatment for patients with hypertension, based on the concept of an old surgical technique [(1)][1]. RDN has been shown to reduce renal norepinephrine spillover [(2)][2], muscle sympathetic nerve activity
No takes yet. Share an insight, caveat, or question.
Mahfoud et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: